Medpace Holdings, Inc.
MEDP
$592.45
-$8.93-1.49%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.78B | 2.68B | 2.53B | 2.36B | 2.23B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.78B | 2.68B | 2.53B | 2.36B | 2.23B |
| Cost of Revenue | 769.32M | 752.59M | 732.13M | 717.50M | 702.70M |
| Gross Profit | 2.01B | 1.93B | 1.80B | 1.64B | 1.53B |
| SG&A Expenses | 189.02M | 187.58M | 197.56M | 198.08M | 199.21M |
| Depreciation & Amortization | 27.80M | 28.10M | 28.12M | 28.50M | 28.97M |
| Other Operating Expenses | 1.21B | 1.15B | 1.04B | 907.26M | 823.40M |
| Total Operating Expenses | 2.20B | 2.12B | 2.00B | 1.85B | 1.75B |
| Operating Income | 583.40M | 562.92M | 534.94M | 507.04M | 477.51M |
| Income Before Tax | 598.92M | 571.80M | 542.38M | 519.43M | 495.37M |
| Income Tax Expenses | 107.42M | 111.40M | 91.25M | 86.42M | 77.07M |
| Earnings from Continuing Operations | 491.50 | 460.40 | 451.12 | 433.01 | 418.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 491.50M | 460.40M | 451.12M | 433.01M | 418.30M |
| EBIT | 583.40M | 562.92M | 534.94M | 507.04M | 477.51M |
| EBITDA | 611.20M | 591.02M | 563.06M | 535.54M | 506.48M |
| EPS Basic | 17.39 | 16.24 | 15.65 | 14.66 | 13.81 |
| Normalized Basic EPS | 13.24 | 12.60 | 11.79 | 11.03 | 10.25 |
| EPS Diluted | 17.05 | 15.90 | 15.29 | 14.30 | 13.45 |
| Normalized Diluted EPS | 12.99 | 12.34 | 11.52 | 10.76 | 9.98 |
| Average Basic Shares Outstanding | 113.05M | 113.47M | 115.42M | 118.07M | 120.98M |
| Average Diluted Shares Outstanding | 115.30M | 115.89M | 118.12M | 121.03M | 124.30M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |